SummaryTo study the factors that determine whether CD4 + T cells produce interleukin 4 (II.-4) or interferon 3' (IFN-3') upon stimulation we used a system allowing naive T cells to be primed in vitro by spedfic antigen. Dense CD4 + T cells were purified from mice that expressed transgenes encoding a T cell receptor specific for pigeon cytochrome C peptide 88-104 in association with I-E k. These T cells produced very limited amounts of Ib4 and IFN-3' upon immediate challenge with 88-104 and antigen-presenting cells (APC). However, after an initial "priming" culture in which they were incubated for 4 d in the presence of 88-104, APC, and 1,000 U/m1 IL-4, the T ceUs acquired the capacity to produce substantial amounts of IL-4 upon rechallenge but made very little IFN-3'. Cells primed in the absence of ID4 produced IFN-3' upon rechallenge but virtually no II.-4. The inhibitory effect of II.-4 on IFN-3' production did no appear to be mediated by the induction of Ibl0 production since IL-10 addition to initial cultures did not suppress priming for IFN-3" production, nor did anti-IL-10 block the inhibitory effect of II.-4. IFN-3' itself did not increase priming for IFN-3' production, nor did anti-IFN-3` reduce such priming. IFN-3` did, however, diminish priming for II.-4 production when limiting amounts of Ib4 (100 U/ml) were used in the initial culture. The dominant effect of Ib4 in determining the lymphokine-producing phenotype of primed cells was observed with dendritic cells (DC), activated B cells, and I-Ek-transfected fibroblasts as APC. However, the different APC did vary in their potency, with DC being superior to activated B cells, which were superior to transfected fibroblasts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.